|
31 |
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
Enthalten in European journal of clinical pharmacology 7.1.2017: 1-8
|
|
|
32 |
Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
Bruland, Philipp. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
|
33 |
Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
Rahimi, Kazem. - Würzburg : Universität Würzburg, 2016
|
|
|
|
34 |
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial
Stingl, Julia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
|
35 |
Measuring spatial accessibility of health care providers – introduction of a variable distance decay function within the floating catchment area (FCA) method
Bauer, Jan. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2016
|
|
|
|
36 |
Mucolytic effectiveness of tyloxapol in chronic obstructive pulmonary disease - a double-blind, randomized controlled trial
Koppitz, Martin. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2016
|
|
|
|
37 |
Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database
Cihoric, Nikola. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
|
38 |
Premature discontinuation of prospective clinical studies approved by a research ethics committee
Blümle, Anette. - Freiburg : Albert-Ludwigs-Universität Freiburg, 2016
|
|
|
|
39 |
Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care
Enthalten in Osteoporosis international 16.12.2016: 1-11
|
|
|
|
40 |
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia
Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015
|
|
Administration
